Literature DB >> 30316735

The clinical value of plasma hepcidin levels in predicting bacterial infections in febrile children.

Jia-Huei Yan1, Xin-Yuan Cai2, Ying-Hsien Huang3.   

Abstract

BACKGROUND: Febrile children are often evaluated for the risk of bacterial infections in the pediatric emergency department (PER). Hepcidin is an acute phase inflammatory protein. In this study, we examined the plasma hepcidin levels in febrile children.
METHODS: This study was conducted at a pediatric emergency department with 123 febrile children. We measured plasma hepcidin levels using an enzyme-linked immunosorbent assay. We further evaluated clinical characteristics and routine blood tests along with the hepcidin levels.
RESULTS: We observed significantly higher plasma hepcidin levels in bacterial enteritis (p = 0.026) and combined with urinary tract infection (p = 0.007). Furthermore, hepcidin levels had a significantly positive correlation with CRP level and length of hospital stay (R = 0.296, p = 0.001 and R = 0.213, p = 0.018). Hepcidin levels greater than 65 ng/mL also more accurately predicted bacterial infections than values below 65 ng/mL (11.7% vs. 2.1%, Odds ratio 8.4, 95% confident interval 1.7-40.9, p = 0.002).
CONCLUSION: This study provides evidence that febrile children with bacterial infection have higher plasma hepcidin levels, and the values correlated with CRP level and length of hospital stay. Therefore, hepcidin values can potentially be adopted as a biomarker for identifying febrile children with bacterial infection, particularly bacterial enteritis and urinary tract infection.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  CRP; bacterial infection; children; hepcidin

Mesh:

Substances:

Year:  2018        PMID: 30316735     DOI: 10.1016/j.pedneo.2018.09.001

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  3 in total

1.  Hepcidin discriminates sepsis from other critical illness at admission to intensive care.

Authors:  Jon Olinder; Alex Börjesson; Jakob Norrman; Tobias West; Joakim Carlström; Alexander Gustafsson; Martin Annborn; Heiko Herwald; Cecilia Rydén
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

2.  Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study.

Authors:  Kreon Koukoulas; Vasiliki Lygoura; Philip Kartalidis; Nikolaos K Gatselis; Efthymia Petinaki; George N Dalekos; George Simos
Journal:  Diagnostics (Basel)       Date:  2022-06-06

3.  Combination of Hemoglobin-for-Age Z-Score and Plasma Hepcidin Identified as a Novel Predictor for Kawasaki Disease.

Authors:  Ya-Ling Yang; Ho-Chang Kuo; Kuang-Den Chen; Chi-Hsiang Chu; Kuang-Che Kuo; Mindy Ming-Huey Guo; Ling-Sai Chang; Ying-Hsien Huang
Journal:  Children (Basel)       Date:  2022-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.